Biochemical characterization of laboratory mutants of extended-spectrum β-lactamase TEM-60

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 9, 2004, Pages 3579-3582

  Caporale, Bibiana ^a   Franceschini, Nicola ^a   Perilli, Mariagrazia ^a   Segatore, Bernardetta ^a   Rossolini, Gian Maria ^b   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ARGININE; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE TEM 60; CEFALORIDINE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; ENZYME INHIBITOR; GLUTAMIC ACID; LEUCINE; LYSINE; MUTANT PROTEIN; NITROCEFIN; PENICILLIN G; PROLINE; SERINE; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CHEMICAL ANALYSIS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME STABILITY; MUTANT; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHEMISTRY, PHYSICAL; DNA PRIMERS; ENZYME INHIBITORS; ESCHERICHIA COLI; KINETICS; MUTAGENESIS, SITE-DIRECTED; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4344676444     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.9.3579-3582.2004     Document Type: Article

References (13)

1. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
2. De Meester, F., J. M. Frère, S. G. Waley, S. J. Cartwright, R. Virden, and F. Lindberg. 1986. 6-β-Iodopenicillanate as a probe for the classification of β-lactamases. Biochem. J. 239:575-580.
3. Franceschini, N., M. Perilli, B. Segatore, D. Setacci, G. Amicosante, A. Mazzariol, and G. Cornaglia. 1998. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum β-lactamase, TEM-60. Antimicrob. Agents Chemother. 42:1459-1462.
4. Galleni, M., N. Franceschini, B. Quinting, L. Fattorini, G. Orefici, A. Oratore, J. M. Frère, and G. Amicosante. 1994. Use of the chromosomal class A β-lactamase of Mycobacterium fortuilum D316 to study potentially poor substrates and inhibitory β-lactam compounds. Antimicrob. Agents Chemother. 38:1608-1614.
5. Jacobv, G. A. 1997. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect. Dis. Clin. N. Am. 11:875-887.
6. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
7. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature (London) 227:680-685.
8. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Perilli, M., B. Segatore, M. R. De Massis, N. Franceschini, C. Bianchi, G. M. Rossolini, and G. Amicosante. 2002. Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey. Antimicrob. Agents Chemother. 46:925-928.
10. Raquet, X., J. Lamotte-Brasseur, E. Fonzè, S. Goussard, P. Courvalin, and J. M. Frère. 1994. TEM β-lactamase mutants hydrolysing third-generation cephalosporins. J. Mol. Biol. 244:625-639.
11. Sambrook, J. E. F. Fritsch, and T. Maniatis. 2001. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
12. Steffan, N. H., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using a polymerase chain reaction. Gene 77:51-59.
13. Vakulenko, S., and D. Golemi. 2002. Mutant TEM β-lactamase producing resistance to ceftazidime, ampicillins, and β-lactamase inhibitors. Antimicrob. Agents Chemother. 46:646-653.